Yao Changyin, Feng Bao, Li Shurong, Lin Fan, Ma Changyi, Cui Jin, Liu Yu, Wang Ximiao, Cui Enming
Department of Radiology, Jiangmen Central Hospital, Jiangmen, China.
Guangdong Medical University, Zhanjiang, China.
Abdom Radiol (NY). 2025 May;50(5):2152-2159. doi: 10.1007/s00261-024-04593-1. Epub 2024 Sep 23.
Some clinicopathological risk stratification systems (CRSSs) such as the leibovich score have been used to predict the postoperative prognosis of patients with clear cell renal cell carcinoma (ccRCC), but there are no reliable noninvasive preoperative indicators for predicting postoperative prognosis in clinical practice.
To assess the value of a deep learning (DL) model based on CT images in predicting the postoperative prognosis of patients with ccRCC.
A total of 382 patients with ccRCC were retrospectively enrolled andallocated to training (n = 229) or testing (n = 153) cohorts at a 6:4 ratio. The features were extracted from precontrast-phase (PCP), corticomedullary-phase (CMP) and nephrographic-phase (NP) CT images with ResNet50, and then extreme learning machines (ELMs) were used to construct classification models. The DL model and Leibovich score were compared and combined. A receiver operating characteristic (ROC) curve and integrated discrimination improvement (IDI) were used to evaluate model performance.
Compared with other single-phase DL models, the three-phase CT-based DL model achieved the best performance, with an area under the curve (AUC) of 0.839. Combining the three-phase DL model and the Leibovich score (AUC = 0.823) into a nomogram (AUC = 0.888) statistically improved performance (IDI = 0.1358, IDI = 0.1393, [Formula: see text]< 0.001).
The CT-based DL model could be valuable for preoperatively predicting the prognosis of patients with ccRCC, and combining it with the Leibovich score can further improve its predictive performance.
一些临床病理风险分层系统(CRSSs),如莱博维奇评分,已被用于预测透明细胞肾细胞癌(ccRCC)患者的术后预后,但在临床实践中,尚无可靠的非侵入性术前指标来预测术后预后。
评估基于CT图像的深度学习(DL)模型在预测ccRCC患者术后预后中的价值。
回顾性纳入382例ccRCC患者,按6:4的比例分为训练组(n = 229)和测试组(n = 153)。使用ResNet50从平扫期(PCP)、皮髓质期(CMP)和肾实质期(NP)CT图像中提取特征,然后使用极限学习机(ELM)构建分类模型。对DL模型和莱博维奇评分进行比较和联合。采用受试者操作特征(ROC)曲线和综合判别改善(IDI)评估模型性能。
与其他单相DL模型相比,基于三相CT的DL模型性能最佳,曲线下面积(AUC)为0.839。将三相DL模型和莱博维奇评分(AUC = 0.823)整合到列线图中(AUC = 0.888),统计学上提高了性能(IDI = 0.1358,IDI = 0.1393,[公式:见正文]<0.001)。
基于CT的DL模型对术前预测ccRCC患者的预后具有重要价值,将其与莱博维奇评分相结合可进一步提高其预测性能。